Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells (Q41676053)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 1999

Language	Label	Description	Also known as
English	Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells	scientific article published on June 1999

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells (English)

1 reference

Europe PubMed Central

6 October 2017

author name string

Goetze S

1

1 reference

Europe PubMed Central

6 October 2017

Xi XP

2

1 reference

Europe PubMed Central

6 October 2017

Graf K

3

1 reference

Europe PubMed Central

6 October 2017

Fleck E

4

1 reference

Europe PubMed Central

6 October 2017

Hsueh WA

5

1 reference

Europe PubMed Central

6 October 2017

Law RE

6

1 reference

Europe PubMed Central

6 October 2017

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

6 October 2017

1 reference

Europe PubMed Central

6 October 2017

452

1 reference

Europe PubMed Central

6 October 2017

3

1 reference

Europe PubMed Central

6 October 2017

277-282

1 reference

Europe PubMed Central

6 October 2017

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Protein kinase C mediation of Ca(2+)-independent contractions of vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Nucleolin is a protein kinase C-zeta substrate. Connection between cell surface signaling and nucleus in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Protein kinase C zeta isoform is critical for mitogenic signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Protein kinase C group B members PKC-delta, -epsilon, -zeta and PKC-L(eta). Comparison of properties of recombinant proteins in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

zeta-Related protein kinase C in nuclei of nerve cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

21 January 2018

The MAPK signaling cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

The smooth muscle cell in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900624-9

7 January 2021

Identifiers

10.1016/S0014-5793(99)00624-9

1 reference

Europe PubMed Central

6 October 2017

1 reference

Europe PubMed Central

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41676053&oldid=1925852167"